Revisiting the WHO classification system of bone tumours: emphasis on advanced magnetic resonance imaging sequences. Part 2
- PMID: 32999694
- PMCID: PMC7509892
- DOI: 10.5114/pjr.2020.98686
Revisiting the WHO classification system of bone tumours: emphasis on advanced magnetic resonance imaging sequences. Part 2
Abstract
Similarly to soft tissue tumours, the World Health Organisation (WHO) classification categorises bone tumours based on their similarity to normal adult tissue. The most recent WHO classification provides an updated classification scheme that integrates the biological behaviour of bone tumours, particularly cartilage-forming tumours, and tumours are now further subdivided as benign, intermediate (locally aggressive or rarely metastasising), and malignant. Radiologists play an important role in the detection and initial characterisation of bone tumours, with careful analysis of their matrix mineralisation, location, and overall anatomic extent including extra-compartmental extension and neurovascular invasion. Radiography remains central to the detection and characterisation of bone tumours; however, magnetic resonance imaging (MRI) is the ideal modality for local staging. This review will discuss the most recent updates to the WHO classification of bone tumours that are relevant to radiologists in routine clinical practice. The utility of advanced MRI sequences such as diffusion-weighted imaging, dynamic contrast enhanced sequences, and magnetic resonance spectroscopy that may provide insight into the biological behaviour of various bone tumours is highlighted.
Keywords: MRI; WHO classification; bone tumours; sarcoma.
Copyright © Polish Medical Society of Radiology 2020.
Conflict of interest statement
The authors report no conflict of interest.
Figures
References
-
- Bridge JA, Hogendoorn PCW, Mertens F. Fletcher CDM. (eds.). WHO Classification of Tumors of Soft Tissue and Bone F, Vol. 5 4th Lyon: International Agency for Research on Cancer Press; 2013, pp. 12-224.
-
- Carney JA, Boccon-Gibod L, Jarka DE, et al. . Osteochondromyxoma of bone: a congenital tumor associated with lentigines and other unusual disorders. Am J Surg Pathol 2001; 25: 164-176. - PubMed
-
- Douis H, Parry M, Vaiyapuri S, et al. . What are the differentiating clinical and MRI-features of enchondromas from low-grade chondrosarcomas? Eur Radiol 2018; 28: 398-409. - PubMed
-
- De Coninck T, Jans L, Sys G, et al. . Dynamic contrast-enhanced MR imaging for differentiation between enchondroma and chondrosarcoma. Eur Radiol 2013; 23: 3140-3152. - PubMed
-
- Douis H, Jeys L, Grimer R, et al. . Is there a role for diffusion-weighted MRI (DWI) in the diagnosis of central cartilage tumors? Skeletal Radiol 2015; 44: 963-969. - PubMed
Publication types
LinkOut - more resources
Full Text Sources